Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Equity (2017 - 2026)

Ovid Therapeutics filings provide 10 years of Return on Equity readings, the most recent being 0.0% for Q1 2026.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity hit 0.0% in Q1 2026 for Ovid Therapeutics, up from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q1 2026 and bottomed at 0.01% in Q3 2025.
  • Average Return on Equity over 5 years is 0.0%, with a median of 0.0% recorded in 2023.
  • The largest annual shift saw Return on Equity dropped -1bps in 2022 before it changed 0bps in 2023.
  • Ovid Therapeutics' Return on Equity stood at 0.0% in 2022, then tumbled by -40bps to 0.01% in 2023, then soared by 34bps to 0.0% in 2024, then skyrocketed by 46bps to 0.0% in 2025, then increased by 26bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for OVID's Return on Equity are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).